These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11853366)

  • 1. Cigarette smoking is a risk factor for nephropathy and its progression in type 2 diabetes mellitus.
    Gambaro G; Bax G; Fusaro M; Normanno M; Manani SM; Zanella M; Dangelo A; Fedele D; Favaro S
    Diabetes Nutr Metab; 2001 Dec; 14(6):337-42. PubMed ID: 11853366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.
    Ravid M; Brosh D; Ravid-Safran D; Levy Z; Rachmani R
    Arch Intern Med; 1998 May; 158(9):998-1004. PubMed ID: 9588433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Smoking Tobacco After a Diagnosis of Diabetes and the Prevalence of Diabetic Nephropathy in the Korean Male Population.
    Yeom H; Lee JH; Kim HC; Suh I
    J Prev Med Public Health; 2016 Mar; 49(2):108-17. PubMed ID: 27055547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking is associated with progression of diabetic nephropathy.
    Sawicki PT; Didjurgeit U; Mühlhauser I; Bender R; Heinemann L; Berger M
    Diabetes Care; 1994 Feb; 17(2):126-31. PubMed ID: 8137682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking exacerbates and its cessation ameliorates renal injury in type 2 diabetes.
    Chuahirun T; Simoni J; Hudson C; Seipel T; Khanna A; Harrist RB; Wesson DE
    Am J Med Sci; 2004 Feb; 327(2):57-67. PubMed ID: 14770020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
    Chuahirun T; Khanna A; Kimball K; Wesson DE
    Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus.
    Boronat M; García-Cantón C; Quevedo V; Lorenzo DL; López-Ríos L; Batista F; Riaño M; Saavedra P; Checa MD
    Ren Fail; 2014 Mar; 36(2):166-70. PubMed ID: 24059817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy.
    Phisitkul K; Hegazy K; Chuahirun T; Hudson C; Simoni J; Rajab H; Wesson DE
    Am J Med Sci; 2008 Apr; 335(4):284-91. PubMed ID: 18414067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function in long-duration type I diabetes.
    Mackin P; Macleod JM; New JP; Marshall SM
    Diabetes Care; 1996 Mar; 19(3):249-51. PubMed ID: 8742571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study.
    Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P;
    Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics associated with microalbuminuria in an adult diabetic population.
    Tung P; Ginier P; Levin SR; Hershman JD; Hershman JM
    J Diabet Complications; 1990; 4(1):15-20. PubMed ID: 2141840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between cigarette smoking and diabetic nephropathy in Chinese male patients.
    Han Q; Wang S; Zhang J; Zhang R; Guo R; Wang Y; Li H; Xu H; Liu F
    Acta Diabetol; 2018 Nov; 55(11):1131-1141. PubMed ID: 30066043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.
    Powrie JK; Watts GF; Ingham JN; Taub NA; Talmud PJ; Shaw KM
    BMJ; 1994 Dec; 309(6969):1608-12. PubMed ID: 7819935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the Burden of Kidney Disease among Type 2 Diabetic Subjects Attending a Semi-Urban Tertiary Health Facility in South-West Nigeria.
    Ikem RT; Lawal-Bello AT; Soyoye DO; Fasanu AN; Kolawole BA
    West Afr J Med; 2023 Jun; 40(6):640-645. PubMed ID: 37390451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
    Ansquer JC; Foucher C; Rattier S; Taskinen MR; Steiner G;
    Am J Kidney Dis; 2005 Mar; 45(3):485-93. PubMed ID: 15754270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.
    Biesenbach G; Grafinger P; Janko O; Zazgornik J
    Clin Nephrol; 1997 Sep; 48(3):146-50. PubMed ID: 9342485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.